144 ·Filed May 4, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
This is a routine insider sale notice; no material market impact expected. Monitor for any acceleration of insider selling, but this filing alone does not warrant action.
Final — all horizons settled through T+60d
TVTX ▲ +27.86% at T+60d
NEUTRAL call ✓ call won +27.86% · α vs SPY +25.12% · entry $44.80 → $57.28
T+1d
0.00%
call 0.00% · α -1.38%
$44.80
settled 5mo ago
T+5d
-2.88%
call -2.88% · α -4.86%
$43.51
settled 5mo ago
T+20d
-4.11%
call -4.11% · α -9.06%
$42.96
settled 4mo ago
T+60d
+27.86%
call +27.86% · α +25.12%
$57.28
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Elizabeth Reed, an officer of Travere Therapeutics, filed a Form 144 to sell 20,000 shares of common stock valued at approximately $900,000, acquired via stock option exercise. The sale is part of ongoing insider selling, but the amount relative to market cap is small and not material.
Key Facts
- Elizabeth Reed (officer) intends to sell 20,000 shares
- Estimated value of $900,000
- Shares acquired via stock option exercise
- Sale to be executed through Morgan Stanley
Financial Impact
Not specified
Risk Factors
- Potential further insider selling
- Stock option exercises may signal insider sentiment if large relative to holdings
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (21 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003951 |
| Document: 0001950047-26-003951-index.html | 0001950047-26-003951 |
| Document: 0001950047-26-003951.txt | 0001950047-26-003951 |
16 reports for TVTX
100% Hit rate best @ T+60▲ +56.24%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 9, 2026 12w ago | 8-K | $56.59 $61.32 | ▲ +8.36% | ▲ +5.93% | $56.93 (+0.60%) |
Jun 16, 2026 15w ago | Insider Cluster | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 16, 2026 15w ago | 8-K | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 12, 2026 16w ago | 144 | $52.04 $56.59 | ▲ +8.74% | ▲ +6.96% | $56.93 (+9.40%) |
Jun 2, 2026 17w ago | 8-K | $42.96 $56.34 | ▲ +31.15% | ▲ +32.71% | $56.93 (+32.52%) |
May 15, 2026 20w ago | 144 | $42.59 $53.80 | ▲ +26.32% | ▲ +24.20% | $56.93 (+33.67%) |
May 5, 2026 21w ago | 144 | $44.76 $45.20 | ▲ +0.98% | ▼ −1.80% | $56.93 (+27.19%) |
May 4, 2026 21w ago | 144 | $44.80 $42.96 | ▼ −4.11% | ▼ −9.06% | $56.93 (+27.08%) |
May 1, 2026 22w ago | Insider Cluster | $44.12 $45.04 | ▼ −2.09% | ▲ +3.20% | $56.93 (−29.03%) |
Apr 15, 2026 24w ago | 144 | $40.95 $42.84 | ▲ +4.62% | ▼ −1.43% | $56.93 (+39.02%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Mon (64h 20m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access